Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-01-01 @ 4:16 AM
Study NCT ID:
NCT01710267
Status:
COMPLETED
Last Update Posted:
2015-04-01
First Post:
2012-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)
Sponsor:
Prof. Dr. Dr. med. Walter A. Wuillemin, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
12041
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None